联合阻断Stat3和HIF-1α对低氧条件下喉癌细胞放化疗的增敏作用

孙亚敬, 路秀英, 李晓明. 联合阻断Stat3和HIF-1α对低氧条件下喉癌细胞放化疗的增敏作用[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(4): 352-356. doi: 10.13201/j.issn.1001-1781.2015.04.015
引用本文: 孙亚敬, 路秀英, 李晓明. 联合阻断Stat3和HIF-1α对低氧条件下喉癌细胞放化疗的增敏作用[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(4): 352-356. doi: 10.13201/j.issn.1001-1781.2015.04.015
SUN Yajing, LU Xiuying, LI Xiaoming. Combined inhibition of Stat3 and HIF-1α for enhancement of radio-and chemo-sensitivity in laryngeal squamous cell carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(4): 352-356. doi: 10.13201/j.issn.1001-1781.2015.04.015
Citation: SUN Yajing, LU Xiuying, LI Xiaoming. Combined inhibition of Stat3 and HIF-1α for enhancement of radio-and chemo-sensitivity in laryngeal squamous cell carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(4): 352-356. doi: 10.13201/j.issn.1001-1781.2015.04.015

联合阻断Stat3和HIF-1α对低氧条件下喉癌细胞放化疗的增敏作用

详细信息
    通讯作者: 李晓明,E-mail:xmlmo@126.com
  • 中图分类号: R739.65

Combined inhibition of Stat3 and HIF-1α for enhancement of radio-and chemo-sensitivity in laryngeal squamous cell carcinoma

More Information
  • 目的: 研究信号转导子和转录激活子3(Stat3)和低氧诱导因子-1α(HIF-1α)对低氧条件下喉癌Hep-2细胞放疗及化疗抵抗作用的影响。方法: 应用Western blot技术检测低氧条件下喉癌Hep-2细胞中p-Stat3和HIF-1α蛋白的表达。MTT比色法分别检测单独和联合抑制Stat3和HIF-1α喉癌Hep-2细胞放疗及化疗后细胞的增殖情况。结果: ①AG490在体外低氧条件下能够有效抑制Hep-2细胞及稳定转染HIF-1αshRNA的Hep-2(Hep-2HIF-1α-/-)细胞的生长(P<0.05);②抑制Stat3表达后HIF-1α的表达下调(P<0.05);③联合阻断HIF-1α和Stat3信号通路后能增强喉癌Hep-2细胞对放化疗的敏感性。结论: 联合阻断HIF-1α和STAT3信号通路较单独阻断HIF-1α或STAT3信号通路能进一步增强喉癌Hep-2细胞对放化疗的敏感性。在有效阻断HIF-1α直接信号通路的同时封闭STAT3旁侧调节通路,有助于进一步提高头颈鳞状细胞癌肿瘤细胞对放化疗的敏感性,并为减少治疗抵抗提供一个新的思路和方法。
  • 加载中
  • [1]

    1KARAR J,MAITY A.Modulating the tumor microenvironment to increase radiation responsiveness[J].Cancer Biol Ther,2009,8:1994-2001.

    [2]

    CUMMINS E P,TAYLOR C T.Hypoxia-responsive transcription factors[J].Pflugers Arch,2005,450:363-371.

    [3]

    JUNG J E,LEE H G,CHO I H,et al.STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells[J].FASEB J,2005,19:1296-1298.

    [4]

    XU Q,BRIGGS J,PARK S,et al.Targeting Stat3 blocks both HIF-1and VEGF expression induced by multiple oncogenic growth signaling pathways[J].Oncogene,2005,24:5552-5560.

    [5]

    POUYSSEGUR J,DAYAN F,MAZURE N M.Hypoxia signalling in cancer and approaches to enforce tumour regression[J].Nature,2006,441:437-443.

    [6]

    SEMENZA G L.HIF-1:upstream and downstream of cancer metabolism[J].Curr Opin Genet Dev,2010,20:51-56.

    [7]

    路秀英,李晓明.低氧条件下喉癌Hep-2细胞Stat3和HIF-1α表达关系的研究[J].中国癌症防治杂志,2012,3(4):284-287.

    [8]

    JUNG J E,KIM H S,LEE C S,et al.STAT 3inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination[J].Exp Mol Med,2008,40:479-485.

    [9]

    LI D,ZHOU L,JIN B,et al.Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells[J].Otolaryngol Head Neck Surg,2013,148:75-81.

    [10]

    李震,屈永涛,李晓明,等.缺氧诱导因子1α反义寡核苷酸对喉鳞状细胞癌的放疗增效作用[J].中国耳鼻咽喉头颈外科,2010,17(11):586-589.

    [11]

    刘春玲,李晓明,路秀英,等.HIF-1α反义寡核苷酸对喉鳞状细胞癌Hep-2细胞放疗的增效作用[J].临床耳鼻咽喉头颈外科杂志,2007,21(13):605-608.

    [12]

    CORZO C A,CONDAMINE T,LU L,et al.HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment[J].J Exp Med,2010,207:2439-2453.

    [13]

    HARADA H,INOUE M,ITASAKA S,et al.Cancer cells that survive radiation therapy acquire HIF-1activity and translocate towards tumour blood vessels[J].Nat Commun,2012,3:783-783.

    [14]

    RAWLINGS J S,ROSLER K M,HARRISON D A.The JAK/STAT signaling pathway[J].J Cell Sci,2004,117:1281-1283.

    [15]

    KAMRAN M Z,PATIL P,GUDE R P.Role of STAT3 in cancer metastasis and translational advances[J].Biomed Res Int,2013,2013:421821.

  • 加载中
计量
  • 文章访问数:  46
  • PDF下载数:  27
  • 施引文献:  0
出版历程
收稿日期:  2014-09-11

目录